Riggs Asset Managment Co. Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $360 Million
- Q2 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 39 shares of REGN stock, worth $23,400. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39
Previous 46
15.22%
Holding current value
$23,400
Previous $29,000
31.03%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,421Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.65 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.07 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.39 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.9 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.3 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...